ALDH1A1 Antibodies

Santa Cruz Biotechnology features a diverse variety of ALDH1A1 monoclonal antibodies for investigating aldehyde dehydrogenase 1A1 in biological processes. ALDH1A1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ALDH1A1 is a key enzyme responsible for aldehyde detoxification and plays an essential role in retinoid metabolism, which drives cellular differentiation and development. ALDH1A1 expression serves as a marker for stem cell characteristics and has been linked to various cancer types, making it an important focus in therapeutic research. Research involving ALDH1A1 continues to reveal new insights into tumor biology and potential treatment approaches. Studying ALDH1A1 expression patterns helps researchers understand its role in normal development and disease progression. Advanced research techniques using ALDH1A1 monoclonal antibodies enable detailed analysis of protein localization and interaction networks. Understanding ALDH1A1 regulation mechanisms provides valuable information about cellular metabolism and stem cell maintenance. Santa Cruz Biotechnology monoclonal antibodies for ALDH1A1 support researchers worldwide in advancing scientific knowledge and developing innovative therapeutic strategies.